OVXA — Ovoca Bio Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- €0.78m
- -€1.62m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.43 | 2.28 | 2.53 | 5.33 | 5.58 |
Operating Profit | -2.43 | -2.28 | -2.53 | -5.33 | -5.58 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2 | -1.9 | -2.32 | -5.25 | -5.61 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2 | -1.9 | -2.32 | -5.25 | -5.61 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.36 | -1.57 | -2.34 | -5.47 | -5.61 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.36 | -1.57 | -2.34 | -5.47 | -5.61 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.016 | -0.018 | -0.028 | -0.064 | -0.065 |
Dividends per Share |